PYXS — Pyxis Oncology Share News
0.000.00%
Last trade - 00:00- $200.90m
- $167.90m
- $13.86m
Pyxis Oncology Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Pyxis Oncology Announces Up To $114 Million Private Placement Financing To Advance Micvo Through Key Clinical Milestones
Pyxis Oncology Q1 net loss widens on higher clinical trial costs
Brief: Pyxis Oncology Q1 Net Income USD -23.272 Million
Pyxis Oncology 2025 net loss widens on higher R&D spend
Brief: Pyxis Oncology Names Thomas Civik as Interim CEO
Pyxis Oncology reports Q3 net loss of $22 mln
Brief: Pyxis Oncology Appoints Alex Kane As Senior Vice President, Investor Relations & Capital Markets
Brief: Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule
Pyxis Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Pyxis Oncology Q2 Net Income USD -18.354 Million
Pyxis Oncology Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Pyxis Oncology- On July 1, Pamela Connealy Retires As CFO And COO
Brief: Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pyxis Oncology Inc reports results for the quarter ended March 31 - Earnings Summary
Pyxis Oncology Inc expected to post a loss of 29 cents a share - Earnings Preview
Pyxis Oncology Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY
Brief: Pyxis Oncology FY Net Income USD -77.331 Million